An opportunity for advancing medical research in Cambridge
An opportunity to visit the Babraham Research Campus to:
- Hear about some of the biomedical research initiatives
- Identify opportunities for collaboration and research support
- Find out about some of the companies located on the Campus that can facilitate medical research in Cambridge
Speaker List: Derek Jones, Chief Executive; Babraham Bioscience Technologies Ltd
Richard Mason; XO1 Ltd "Ichorcumab - a CUH/CU/Babraham co-production"
Klaus Okkenhaug; Babraham Institute "P13K in immunity, infection and cancer"
Heather Fairhead; Phico Therapeutics Ltd “SASPject – a novel antibacterial technology”
Myriam Hemberger; Babraham Institute “Getting the first steps right: Early trophoblast development for normal reproduction and lifelong health”
Niall Martin; MISSION Therapeutics Ltd “Drugging the ubiquitin pathway for novel anticancer agents”
Simon Cook; Babraham Institute “Understanding acquired resistance to targeted kinase inhibitors”
Mike Romanos; Crescendo Biologics Ltd “A novel topical biologic for psoriasis derived from the Crescendo Mouse”
Anne Corcoran; Babraham Institute “Regulation of antibody repertoire”
Simon Tate; Convergence Pharmaceuticals Ltd “Clinical efficacy of the novel sodium channel blocker CNV1014802 in chronic pain”